You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms, Multiple Primary

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

New Echocardiographic Indicators in Treatment of Primary

Not yet recruiting
  • Multiple Myeloma
  • Chemotherapy and/or autologous hematopoietic stem cell transplantation
  • (no location specified)
Sep 18, 2023

Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive

Recruiting
  • Kidney Cancer
  • +2 more
  • Cytoreductive nephrectomy±metastasectomy
  • Human-derived materials sampling
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 2, 2023

Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)

Not yet recruiting
  • Multiple Myeloma
  • Primary Plasma Cell Leukemia
  • Experimental: CAR-T cells Infusion
  • Shanghai, China
    Shanghai Changzheng Hospital
Apr 20, 2023

Natural History Study of Parathyroid Disorders

Recruiting
  • Parathyroid Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Microbial Colonization, Esophageal Cancer, Oropharyngeal Tumors Trial in Tainan (Oral swab test)

    Recruiting
    • Microbial Colonization
    • +3 more
    • Oral swab test
    • Tainan, Other (Non U.s.), Taiwan
      National Cheng-Kung University Hospital
    Jun 6, 2022

    Multiple Myeloma Trial in Lanzhou (Pomalidomide)

    Recruiting
    • Multiple Myeloma
    • Lanzhou, Gansu, China
      The First Hospital of Lanzhou University
    Jul 9, 2022

    Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Wuhan, Hubei, China
      Institute of Hematology, Union Hospital, Tongji Medical College,
    Nov 18, 2023

    Multiple Cancer, Colorectal Cancer Trial (MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 mAb neoadjuvant

    Not yet recruiting
    • Multiple Cancer
    • Colorectal Cancer
    • MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy
    • All-MSI-H (dMMR) sMPCC: single-drug PD-1 monoclonal antibody neoadjuvant therapy
    • (no location specified)
    Aug 20, 2023

    Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan,

    Recruiting
    • Liver Metastasis Colon Cancer
    • Synchronous Neoplasm
    • Neo-adjuvant Chemotherapy FOLFOXIRI Regimen
    • synchronous resection surgery
    • Ho Chi Minh City, Vietnam
      Cho Ray hospital- 201 B Nguyen Chi Thanh, District 5
    May 5, 2022

    Multiple Primary Cancers Trial in Shanghai (ct-DNA guided therapy)

    Not yet recruiting
    • Multiple Primary Cancers
    • ct-DNA guided therapy
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cencer Center
    Dec 7, 2021

    Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

    Completed
    • Multiple Myeloma
    • +7 more
    • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Nov 2, 2022

    Malignant Tumors of Independent (Primary) Multiple Sites Trial in Houston (Questionnaires, Video Presentation)

    Active, not recruiting
    • Malignant Neoplasms of Independent (Primary) Multiple Sites
    • Questionnaires
    • Video Presentation
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jun 29, 2022

    Expectations Regarding Mobility and Self-Care

    Active, not recruiting
    • Benign Neoplasms
    • Malignant Neoplasms of Independent (Primary) Multiple Sites
    • Questionnaires
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Apr 28, 2022

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Brain Metastases, Adult Trial in Leuven (Stereotactic radiotherapy)

    Recruiting
    • Brain Metastases, Adult
    • Stereotactic radiotherapy
    • Leuven, Belgium
      UZLeuven
    Oct 21, 2021

    Ovarian Cancer, Endometrial Cancer, Ovary Tumor Trial in Multiple Locations (Physician's choice according to patient's needs.)

    Recruiting
    • Ovarian Cancer
    • +6 more
    • Physician's choice according to patient's needs.
    • Multiple Locations, Germany
      Multiple sites all over Germany
    Dec 1, 2021

    Malignant Tumor of Bone and Articular Cartilage, Malignant Tumors of Female Genital Organs, Malignant Tumors of Independent

    Recruiting
    • Malignant Neoplasm of Bone and Articular Cartilage
    • +9 more
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Oct 26, 2022

    Multiple Primary Lung Cancer Trial in Shanghai (Microwave ablation plus Camrelizumab, Microwave ablation)

    Recruiting
    • Multiple Primary Lung Cancer
    • Microwave ablation plus Camrelizumab
    • Microwave ablation
    • Shanghai, Shanghai, China
    • +5 more
    Sep 13, 2021

    Malignant Tumors of Independent (Primary) Multiple Sites Trial in Houston (other, behavioral, device)

    Not yet recruiting
    • Malignant Neoplasms of Independent (Primary) Multiple Sites
    • Tongue Assessment
    • +4 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Feb 25, 2022

    Brain Metastases Trial in Innsbruck (Hippocampal Avoiding Whole Brain Radiation Therapy with Simultaneous Integrated Boost,

    Recruiting
    • Brain Metastases
    • Hippocampal Avoiding Whole Brain Radiation Therapy with Simultaneous Integrated Boost
    • Single session or hypofractionated stereotactic radiosurgery
    • Innsbruck, Austria
      Medical University Innsbruck
    Sep 2, 2021

    Multiple Primary Lung Cancer Trial (Stereotactic Ablation Radiotherapy, Sintilimab)

    Not yet recruiting
    • Multiple Primary Lung Cancer
    • (no location specified)
    Apr 8, 2021

    MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

    Active, not recruiting
    • MSI-H Colorectal Cancer
    • +30 more
    • Badalona, Barcelona, Spain
    • +9 more
    Oct 24, 2022

    AI & Radiomics for Stratification of Lung Nodules After

    Recruiting
    • Indeterminate Pulmonary Nodules
    • +3 more
    • Non-Interventional Study
    • London, United Kingdom
    • +1 more
    May 17, 2022

    Mitochondrial Dysfunction in Primary Progressive Multiple

    Recruiting
    • Multiple Sclerosis
      • Milan, MI, Italy
      • +1 more
      Aug 29, 2023

      Frequency of Cachexia in Ambulatory Cancer Patients and

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +6 more
      • Questionnaire Administration
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 1, 2021